Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Dow
Colorcon
Harvard Business School
Federal Trade Commission
Merck
McKinsey
McKesson
Julphar

Generated: July 17, 2018

DrugPatentWatch Database Preview

Candesartan cilexetil; hydrochlorothiazide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for candesartan cilexetil; hydrochlorothiazide and what is the scope of candesartan cilexetil; hydrochlorothiazide patent protection?

Candesartan cilexetil; hydrochlorothiazide
is the generic ingredient in two branded drugs marketed by Ani Pharms Inc, Apotex Inc, Dr Reddys Labs Ltd, Macleods Pharms Ltd, Mylan Pharms Inc, Prinston Inc, and Zydus Pharms Usa Inc, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for candesartan cilexetil; hydrochlorothiazide. Nine suppliers are listed for this compound. There is one tentative approval for this compound.
Summary for candesartan cilexetil; hydrochlorothiazide
Pharmacology for candesartan cilexetil; hydrochlorothiazide
Synonyms for candesartan cilexetil; hydrochlorothiazide
1145777-98-5
ATACAND HCT
Blopress Plus
C33H34N6O6.C7H8ClN3O4S2
Candesartan cilexetil / hydrochlorothiazide
Candesartan cilexetil mixture with hydrochlorothiazide
Cartex-H
Hydrochlorothiazide mixture with Candesartan cilexetil
Hytacand
LS-178477
Ratacand Plus
SCHEMBL2526670
Tentative approvals for CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign Up16MG; 12.5MGTABLET; ORAL
➤ Sign Up➤ Sign Up32MG; 25MGTABLET; ORAL
➤ Sign Up➤ Sign Up32MG; 12.5MGTABLET; ORAL

US Patents and Regulatory Information for candesartan cilexetil; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc ATACAND HCT candesartan cilexetil; hydrochlorothiazide TABLET;ORAL 021093-002 Sep 5, 2000 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Macleods Pharms Ltd CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE candesartan cilexetil; hydrochlorothiazide TABLET;ORAL 204100-002 Feb 27, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Prinston Inc CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE candesartan cilexetil; hydrochlorothiazide TABLET;ORAL 207455-003 Apr 11, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Dr Reddys Labs Ltd CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE candesartan cilexetil; hydrochlorothiazide TABLET;ORAL 202965-001 Jun 3, 2013 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for candesartan cilexetil; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ani Pharms Inc ATACAND HCT candesartan cilexetil; hydrochlorothiazide TABLET;ORAL 021093-002 Sep 5, 2000 ➤ Sign Up ➤ Sign Up
Ani Pharms Inc ATACAND HCT candesartan cilexetil; hydrochlorothiazide TABLET;ORAL 021093-003 May 16, 2008 ➤ Sign Up ➤ Sign Up
Ani Pharms Inc ATACAND HCT candesartan cilexetil; hydrochlorothiazide TABLET;ORAL 021093-001 Sep 5, 2000 ➤ Sign Up ➤ Sign Up
Ani Pharms Inc ATACAND HCT candesartan cilexetil; hydrochlorothiazide TABLET;ORAL 021093-001 Sep 5, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Covington
Teva
Daiichi Sankyo
Accenture
Colorcon
McKesson
Chinese Patent Office
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.